| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 180 | $0.35 | $62.26 (0%) | 🛒 Add to cart |
| 360 | $0.31
Best per cap | $124.51 $111.46 (10%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 60 | $0.67 | $40.17 (0%) | 🛒 Add to cart |
| 90 | $0.60 | $60.25 $54.22 (10%) | 🛒 Add to cart |
| 120 | $0.56 | $80.33 $67.28 (16%) | 🛒 Add to cart |
| 180 | $0.53 | $120.50 $95.39 (21%) | 🛒 Add to cart |
| 270 | $0.51 | $180.75 $137.57 (24%) | 🛒 Add to cart |
| 360 | $0.50
Best per cap | $240.99 $179.74 (25%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
More info:
Fluoxetine: Sustained Serotonin Modulation for Depression and Anxiety - Evidence-Based Review
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant that has fundamentally changed how we approach mood and anxiety disorders since its introduction. As a clinician who’s prescribed it for over two decades, I’ve seen firsthand how this molecule can rewrite life stories—but only when used correctly. The journey from chemical compound to clinical tool is far more nuanced than the pharmacology textbooks suggest. 1. Introduction: What is Fluoxetine? Its Role in Modern Medicine When we talk about fluoxetine in clinical practice, we’re discussing one of the most studied psychotropic medications in history.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in the atypical antipsychotic class with its unique pharmacodynamic profile. Unlike earlier antipsychotics that primarily functioned as dopamine antagonists, aripiprazole acts as a partial dopamine D2 and serotonin 5-HT1A receptor agonist while simultaneously antagonizing serotonin 5-HT2A receptors. This distinctive mechanism—often described as dopamine system stabilization—provides effective symptom control while minimizing side effects like extrapyramidal symptoms and hyperprolactinemia that plagued first-generation agents.
amitriptyline
Amitriptyline is a tricyclic antidepressant (TCA) that’s been in clinical use since the 1960s, primarily indicated for major depressive disorder but possessing a remarkably broad therapeutic profile that extends far beyond its original designation. What’s fascinating is how this older medication has maintained relevance through decades of pharmaceutical innovation, largely due to its multifaceted mechanism and cost-effectiveness. Unlike many newer antidepressants that target specific neurotransmitter systems with precision, amitriptyline exerts effects across multiple pathways, which explains both its efficacy and its side effect profile.
anafranil
Anafranil, known generically as clomipramine, is a tricyclic antidepressant (TCA) primarily used for obsessive-compulsive disorder (OCD). It’s one of those older agents that, frankly, we don’t reach for as a first-line for depression anymore due to side effects, but for OCD? It remains a cornerstone, arguably the most effective pharmacologic agent we have. Its mechanism is distinct, with potent serotonin reuptake inhibition that predates the SSRIs. I remember my first year in psychopharmacology, the attending told me, “If you want to understand OCD treatment, you start and end with clomipramine.
antabuse
Disulfiram, commonly known by its brand name Antabuse, is a pharmacological agent with a very specific and potent mechanism used primarily in the management of chronic alcohol use disorder. It’s not a cure for alcoholism, but rather an aversive therapy that acts as a powerful psychological deterrent against drinking. When a patient on disulfiram consumes even a small amount of alcohol, it triggers a highly unpleasant physiological reaction. This creates a concrete consequence, buying valuable time for the patient to engage in the crucial psychosocial aspects of recovery, like counseling and support groups.
Antivert: Effective Vertigo and Motion Sickness Relief - Evidence-Based Review
Product Description: Antivert represents one of those interesting cases in clinical practice where a well-established pharmaceutical agent crosses over into broader therapeutic use. We’re talking about meclizine hydrochloride - an old-school antihistamine with specific vestibular suppressant properties that’s been helping people manage vertigo and motion sickness since the 1950s. What’s fascinating is how this compound has maintained clinical relevance while newer agents have come and gone. The mechanism is deceptively simple - it blocks histamine H1 receptors in the vestibular system - but the clinical effects can be profound for the right patient population.
bystolic
Bystolic represents one of those interesting beta-blockers that never quite behaves like you’d expect from its class. When we first started using nebivolol in our cardiology practice back in 2008, I’ll admit I was skeptical - just another beta-blocker in an already crowded field, or so I thought. What surprised me was how differently patients responded compared to traditional agents like metoprolol or atenolol. Bystolic: Selective Beta-Blockade with Vasodilatory Properties for Hypertension Management 1.
celexa
Celexa, known generically as citalopram hydrobromide, is a selective serotonin reuptake inhibitor (SSRI) antidepressant medication, not a dietary supplement or medical device. It’s prescribed primarily for major depressive disorder (MDD) in adults. The drug works by increasing serotonin activity in the brain, which helps improve mood, sleep, appetite, and energy levels. Available as oral tablets or liquid solution, Celexa requires a prescription and careful medical supervision due to potential side effects and interactions.
chloroquine
Chloroquine is a 4-aminoquinoline compound that’s been kicking around since the 1930s, originally derived from quinine. Most people think of it as an antimalarial, but its immunomodulatory properties have made it a staple in rheumatology for decades. The chemical structure gives it that unique lysosomotropic character - basically it accumulates in acidic organelles and messes with antigen processing. We’ll get into the nitty-gritty of that mechanism later. I remember my first rotation in infectious diseases back in ‘98 - we had this 62-year-old missionary, Robert, who’d been in Papua New Guinea for six months.